(Reuters) - U.S. drugmaker Merck & Co on Friday said it would pay $830 million to settle a federal class action lawsuit involving allegations the company failed to adequately inform investors about ...

A settlement calling for Merck & Co. to pay $830 million to investors in multidistrict litigation over the painkiller Vioxx and another $232 million in legal fees received preliminary approval Feb. 11 ...

TRENTON, N.J. — Merck & Co. said Friday that it will pay $4.85 billion to end thousands of state and federal lawsuits over its painkiller Vioxx in one of the largest drug settlements ever. Company ...

NEW ORLEANS — Merck & Co. got slammed with two Vioxx trial setbacks on Thursday, calling into question the drug maker's strategy of taking on litigation over the withdrawn painkiller one case at a ...

Jury selection is to begin this week in the first Midwest trial over the painkiller Vioxx, which Merck & Co. withdrew in 2004 after research showed it increased the risk of heart attacks and strokes.

NEW ORLEANS A federal jury ruled in favor of Merck & Co. Inc. on Tuesday in a lawsuit over the painkiller Vioxx, finding there was not enough evidence to link the drug to a Kentucky man's heart attack ...